PhD Owen A. O’Connor MD

  • Citations Per Year
Learn More
T-cell lymphomas (TCLs) classically have a poorer response to therapy when compared with B-cell lymphomas and account for only 10–15% of all lymphoid malignancies. Hepatosplenic TCLs are a rare(More)
  • 1